Screener
Medifast MED Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $76.04M-34.3% | $75.1M-36.9% | $89.41M-36.2% | $105.56M-37.4% | $115.73M-33.8% | ||
| $24.29M-22.9% | $22.96M-25.4% | $27.25M-21.0% | $28.91M-35.9% | $31.48M-33.6% | ||
| $51.76M-38.6% | $52.14M-40.9% | $62.16M-41.2% | $76.64M-37.9% | $84.25M-33.8% | ||
| 68.1%-4.7pp | 69.4%-4.7pp | 69.5%-5.9pp | 72.6%-0.6pp | 72.8%-0.1pp | ||
| $55.05M-35.6% | $59.94M-31.5% | $66.24M-36.0% | $77.71M-40.8% | $85.51M-28.4% | ||
| -$3.3M-161% | -$7.8M-1,201% | -$4.08M-294% | -$1.07M+86.5% | -$1.26M-116% | ||
| -4.3%-3.2pp | -10.4%-11.0pp | -4.6%-6.1pp | -1%+3.7pp | -1.1%-5.6pp | ||
| $1.35M-24.3% | $1.42M+151% | $1.42M+370% | $3.94M+242% | $1.79M-50.9% | ||
| -$1.94M-469% | -$6.38M-601% | -$2.66M-268% | $2.88M+127% | $526K-95.5% | ||
| $181K-86.1% | $11.74M+2,376% | -$396K-188% | $395K+116% | $1.3M-60.3% | ||
| -$2.12M-175% | -$18.12M-2,362% | -$2.26M-300% | $2.48M+130% | -$772K-109% | ||
| -2.8%-2.1pp | -24.1%-24.8pp | -2.5%-3.3pp | 2.3%+7.2pp | -0.7%-5.4pp | ||
| -$0.19-171% | -$1.65-2,457% | -$0.21-310% | $0.22+129% | -$0.07-109% | ||
| $188K-90.7% | -$4.34M-211% | -$629K-112% | $2.98M+162% | $2.02M-82.0% | ||
| 0.2%-1.5pp | -5.8%-9.0pp | -0.7%-4.5pp | 2.8%+5.7pp | 1.7%-4.7pp | ||
| -$3.3M-161% | -$7.8M-1,201% | -$4.08M-294% | -$1.07M+86.5% | -$1.26M-116% |
FAQ
- What is Medifast's revenue?
- Medifast (MED) generated $346.1M in revenue over the trailing twelve months, down 36.3% year over year.
- Is Medifast profitable?
- Medifast is not currently profitable: it reported a net loss of $20.0M over the trailing twelve months, a -5.8% net margin.
- What are Medifast's profit margins?
- Gross margin is 70.1% and operating margin is -4.7%, with a -5.8% net margin.
- What is Medifast's earnings per share?
- Medifast's diluted EPS over the trailing twelve months is $-1.83.
- Where does Medifast's income statement data come from?
- Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
